A computational analysis indicated the BCL6-3′-UTR as a potential target amongst others for miR-205 which was found here to be down-regulated in the EBV-positive NK/T-cell lymphomas and the EBV-negative samples as compared to normal tissue. The gene discussed is BCL6; the disease is T-cell non-Hodgkin lymphoma.